Alnylam Pharmaceuticals (ALNY) EBT (2009 - 2026)
Alnylam Pharmaceuticals posted quarterly EBT of $221.7 million for Q1 2026, up 9460.35% year-on-year from $2.3 million in Q1 2025, and up 156.96% on a QoQ basis from $86.3 million in Q4 2025.
Alnylam Pharmaceuticals (ALNY) has 18 years of EBT data on file, last reported at $221.7 million in Q1 2026.
- For the quarter ending Q1 2026, EBT rose 9460.35% year-over-year to $221.7 million; the trailing twelve-month figure through Mar 2026 stood at $553.1 million (up 274.95% YoY), and the FY2025 full-year result was $323.2 million, up 185.63% from the prior year.
- EBT for Q1 2026 stood at $221.7 million, up from $86.3 million in the prior quarter.
- Across five years, EBT topped out at $280.6 million in Q3 2025 and bottomed at -$405.9 million in Q3 2022.
- The 5-year median for EBT is -$108.7 million (2024), against an average of -$81.6 million.
- The widest annual swing landed in 2025, when EBT sank 216.63%; it then jumped 9460.35% in 2026.
- A 5-year view of EBT shows it stood at -$207.0 million in 2022, then jumped by 33.49% to -$137.7 million in 2023, then tumbled by 40.87% to -$194.0 million in 2024, then surged by 144.47% to $86.3 million in 2025, then jumped by 156.96% to $221.7 million in 2026.
- The last three EBT figures came in at $221.7 million (Q1 2026), $86.3 million (Q4 2025), and $280.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.60 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.31 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.18 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 831.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 221.65 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221.65 Mn |
| Dec 31, 2025 | 86.26 Mn |
| Sep 30, 2025 | 280.57 Mn |
| Jun 30, 2025 | -35.36 Mn |
| Mar 31, 2025 | -2.37 Mn |
| Dec 31, 2024 | -193.96 Mn |
| Sep 30, 2024 | -108.66 Mn |
| Jun 30, 2024 | -11.17 Mn |
| Mar 31, 2024 | -63.59 Mn |
| Dec 31, 2023 | -137.69 Mn |
| Sep 30, 2023 | 150.74 Mn |
| Jun 30, 2023 | -274.21 Mn |
| Mar 31, 2023 | -172.36 Mn |
| Dec 31, 2022 | -207.02 Mn |
| Sep 30, 2022 | -405.94 Mn |
| Jun 30, 2022 | -274.67 Mn |
| Mar 31, 2022 | -239.36 Mn |
| Dec 31, 2021 | -260.30 Mn |
| Sep 30, 2021 | -204.24 Mn |
| Jun 30, 2021 | -188.33 Mn |
| Mar 31, 2021 | -199.28 Mn |
| Dec 31, 2020 | -243.60 Mn |
| Sep 30, 2020 | -252.45 Mn |
| Jun 30, 2020 | -177.90 Mn |
| Mar 31, 2020 | -181.65 Mn |
| Dec 31, 2019 | -276.58 Mn |
| Sep 30, 2019 | -208.93 Mn |
| Jun 30, 2019 | -218.52 Mn |
| Mar 31, 2019 | -181.22 Mn |
| Dec 31, 2018 | -211.08 Mn |
| Sep 30, 2018 | -244.84 Mn |
| Jun 30, 2018 | -163.48 Mn |
| Mar 31, 2018 | -141.28 Mn |
| Dec 31, 2017 | -142.23 Mn |
| Sep 30, 2017 | -122.94 Mn |
| Jun 30, 2017 | -118.42 Mn |
| Mar 31, 2017 | -107.29 Mn |
| Dec 31, 2016 | -113.23 Mn |
| Sep 30, 2016 | -104.47 Mn |
| Jun 30, 2016 | -90.13 Mn |
| Mar 31, 2016 | -102.97 Mn |
| Dec 31, 2015 | -90.72 Mn |
| Sep 30, 2015 | -76.79 Mn |
| Jun 30, 2015 | -71.35 Mn |
| Mar 31, 2015 | -51.21 Mn |
| Dec 31, 2014 | -43.48 Mn |
| Sep 30, 2014 | -43.92 Mn |
| Jun 30, 2014 | -44.39 Mn |
| Mar 31, 2014 | -268.81 Mn |
| Dec 31, 2013 | -29.34 Mn |
| Sep 30, 2013 | -31.96 Mn |
| Jun 30, 2013 | -21.05 Mn |
| Mar 31, 2013 | -9.58 Mn |
| Dec 31, 2012 | 43.64 Mn |
| Sep 30, 2012 | -19.50 Mn |
| Jun 30, 2012 | -12.96 Mn |
| Mar 31, 2012 | -11.37 Mn |
| Dec 31, 2011 | 43.18 Mn |
| Sep 30, 2011 | -13.24 Mn |
| Jun 30, 2011 | -13.82 Mn |
| Mar 31, 2011 | -16.29 Mn |
| Dec 31, 2010 | -6.50 Mn |
| Sep 30, 2010 | -9.33 Mn |
| Jun 30, 2010 | -14.86 Mn |
| Mar 31, 2010 | -12.31 Mn |
| Dec 31, 2009 | -8.23 Mn |
| Sep 30, 2009 | -9.76 Mn |
| Jun 30, 2009 | -21.79 Mn |